ALMS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.191000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.314600E-01
Normal-vs-Stage2
3.022200E-01
Normal-vs-Stage3
5.610400E-02
Normal-vs-Stage4
7.563800E-01
Stage1-vs-Stage2
8.548600E-01
Stage1-vs-Stage3
5.865800E-02
Stage1-vs-Stage4
2.294400E-01
Stage2-vs-Stage3
8.238200E-02
Stage2-vs-Stage4
7.695500E-02
Stage3-vs-Stage4
3.618500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.053800E-01
Normal-vs-AfricanAmerican
8.567600E-01
Normal-vs-Asian
2.181600E-01
Caucasian-vs-AfricanAmerican
2.640200E-01
Caucasian-vs-Asian
3.767400E-01
AfricanAmerican-vs-Asian
1.664590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.109200E-01
Normal-vs-Female
3.404400E-01
Male-vs-Female
7.667600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.766200E-01
Normal-vs-Age(41-60Yrs)
6.432600E-01
Normal-vs-Age(61-80Yrs)
2.333800E-01
Normal-vs-Age(81-100Yrs)
1.218780E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.394600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.330600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.486800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.662700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.763600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.736150E-01
Normal-vs-Daily Drinker
1.619550E-01
Normal-vs-Weekly Drinker
3.168600E-01
Normal-vs-Occasional Drinker
6.165600E-01
Normal-vs-Social Drinker
6.121200E-01
Non Drinker-vs-Daily Drinker
5.190200E-01
Non Drinker-vs-Weekly Drinker
8.276200E-01
Non Drinker-vs-Occasional Drinker
2.009600E-01
Non Drinker-vs-Social Drinker
2.572800E-01
Daily Drinker-vs-Weekly Drinker
5.021200E-01
Daily Drinker-vs-Occasional Drinker
1.153960E-01
Daily Drinker-vs-Social Drinker
1.555440E-01
Weekly Drinker-vs-Occasional Drinker
4.233800E-01
Weekly Drinker-vs-Social Drinker
4.823800E-01
Occasional Drinker-vs-Social Drinker
9.563400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.517700E-02
Normal-vs-Grade 2
1.588500E-02
Normal-vs-Grade 3
1.360100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.849560E-01
Grade 1-vs-Grade 3
5.440000E-02
Grade 1-vs-Grade 4
7.517700E-02
Grade 2-vs-Grade 3
2.655600E-01
Grade 2-vs-Grade 4
1.588500E-02
Grade 3-vs-Grade 4
1.360100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.612640E-01
Normal-vs-NonDiabetic
2.702400E-01
Diabetic-vs-NonDiabetic
3.805600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.287600E-01
Normal-vs-NoPancreatitis
2.581800E-01
Pancreatitis-vs-NoPancreatitis
6.467200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.034000E-01
Normal-vs-N1
3.171200E-01
N0-vs-N1
9.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.755200E-01
Normal-vs-TP53-NonMutant
6.965000E-01
TP53-Mutant-vs-TP53-NonMutant
6.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
